Injectable Drug Delivery Resources

  1. Utilizing Robotic Aseptic Filling Systems To Meet Industry Needs 5/19/2022

    An aseptic filling and closing machine solution allowed Catalent to reliably process a wide range of both trayed and nested vials for their client product needs.

  2. Can You Simplify Device Decisions And Stand Out From Competition? 7/25/2025

    Evaluating your system’s performance and compatibility earlier in development can ensure you have a viable product to support development phases.

  3. Characterization & Delivery Of Ultra-Viscous & Non-Newtonian Formulations 3/2/2022

    Discover how to identify characteristics at the earliest stage, a vital step in autoinjector device platform development, with the use of the innovative Injection Characterization System (ICS).

  4. Build A Vial-Stopper Combination Suitable For Drug Product Storage At -80°C

    This study worked to determine if the chosen vial-stopper-seal combination will remain integral while frozen at -80°C, under studied conditions, when the appropriate materials, processing, and sealing conditions are applied.

  5. De-Risking The Transition From Vial To Drug-Device Combination Product 7/25/2025

    When transitioning from a vial to a combination product system, the best approach is to have a holistic de-risk strategy with an intentional focus on the patient, the plan, and the product.

  6. Switching From Vials To PFS And Intravenous To Subcutaneous Formulations 7/25/2023

    Learn about formulation development challenges for prefilled syringes as well as considerations for reducing the time it takes to launch safer, more convenient, and cost-effective products for the patient.

  7. Viral Vector Based Gene Therapy Drug Products: The Right Primary Container 5/20/2024

    Explore the major considerations for an ideal primary container for viral vector-based gene therapy drug products and the existing and new solutions in this space.

  8. Implantable Drug Delivery: Are We There Yet? 12/22/2025

    Implantable drug delivery offers precise, localized treatment, yet biological barriers and market complexities remain. Explore the factors determining if these systems are ready for broad adoption.

  9. Four Special Fill/Finish Considerations For Vaccine Production

    Examine considerations regarding the handling and process for fill/finish to ensure the stability and purity of your vaccine as well as limit unnecessary waste and cost.

  10. Which Testing Does An Effective Certificate Of Analysis Include? 2/16/2022

    Discerning mandatory testing from supplemental testing for early-stage injectable or IV-infusion therapies streamlines CoA creation and promotes regulatory compliance.